JP Morgan Chase’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-789
Closed -$12.6K 7455
2025
Q3
$12.6K Buy
789
+20
+3% +$329 ﹤0.01% 6583
2025
Q2
$13.6K Sell
769
-6,104
-89% -$119K ﹤0.01% 6257
2025
Q1
$143K Buy
6,873
+2,347
+52% +$44.5K ﹤0.01% 5394
2024
Q4
$83.6K Sell
4,526
-3,746
-45% -$72.1K ﹤0.01% 5818
2024
Q3
$162K Sell
8,272
-76,864
-90% -$1.53M ﹤0.01% 5504
2024
Q2
$1.67M Buy
85,136
+81,868
+2,505% +$1.55M ﹤0.01% 3934
2024
Q1
$58.9K Sell
3,268
-323
-9% -$5.86K ﹤0.01% 5877
2023
Q4
$60.9K Sell
3,591
-808
-18% -$16.1K ﹤0.01% 5936
2023
Q3
$87.4K Sell
4,399
-490
-10% -$9.28K ﹤0.01% 5566
2023
Q2
$91.7K Buy
4,889
+1,672
+52% +$33.7K ﹤0.01% 5504
2023
Q1
$65.6K Buy
3,217
+2,732
+563% +$55K ﹤0.01% 5607
2022
Q4
$10K Buy
+485
New +$10.1K ﹤0.01% 6023

Other funds holding BTAL

JP Morgan Chase's BTAL Position: Q4 2025 in Review

JP Morgan Chase sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 789 shares — an estimated $12.6K sold.

JP Morgan Chase first reported a position in BTAL in Q4 2022 and held it in 12 quarters. The position peaked at $1.67M in Q2 2024. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • JP Morgan Chase reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 789 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $12.6K.
  • JP Morgan Chase first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 12 quarters.
  • JP Morgan Chase's AGF US Market Neutral Anti-Beta Fund position peaked at $1.67M in Q2 2024.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.